PGIM Jennison Health Sciences Fund - Class Z (PHSZX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
41.88
-0.47 (-1.11%)
Jul 11, 2025, 4:00 PM EDT
-19.07%
Fund Assets 1.34B
Expense Ratio 0.86%
Min. Investment $0.00
Turnover 79.00%
Dividend (ttm) 5.40
Dividend Yield 12.76%
Dividend Growth 182.36%
Payout Frequency Annual
Ex-Dividend Date Dec 20, 2024
Previous Close 42.35
YTD Return -3.77%
1-Year Return -1.74%
5-Year Return 51.05%
52-Week Low 37.90
52-Week High 54.68
Beta (5Y) n/a
Holdings 45
Inception Date Jun 30, 1999

About PHSZX

The PGIM Jennison Health Sciences Fund is a mutual fund focused on long-term capital appreciation by investing primarily in the healthcare sector. It targets companies involved in drugs, healthcare services, and biotechnology, aiming to capitalize on the growth potential of these industries. The fund's portfolio is composed of a mix of large-cap healthcare companies, with a significant portion of its assets allocated to top holdings in this sector. Its high-conviction strategy is managed by experienced healthcare specialists, appealing to investors seeking dedicated exposure to the healthcare market. The fund's role in the financial market is to provide a concentrated investment opportunity for those interested in the healthcare industry's potential for growth and innovation.

Fund Family PGIM Investments
Category Health
Stock Exchange NASDAQ
Ticker Symbol PHSZX
Share Class Class Z
Index S&P Composite 1500 Health Care TR

Performance

PHSZX had a total return of -1.74% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.97%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
PHLQX Class R6 0.77%
PHLAX Class A 1.13%
PJHRX Class R 1.48%
PHLCX Class C 1.96%

Top 10 Holdings

57.84% of assets
Name Symbol Weight
Eli Lilly and Company LLY 14.60%
Prudential Govt Money Mkt Fd n/a 10.96%
Vertex Pharmaceuticals Incorporated VRTX 4.95%
argenx SE ARGX 4.85%
Neurocrine Biosciences, Inc. NBIX 4.78%
AstraZeneca PLC AZN 4.64%
Thermo Fisher Scientific Inc. TMO 3.58%
Novo Nordisk A/S NVO 3.50%
Alnylam Pharmaceuticals, Inc. ALNY 3.15%
UnitedHealth Group Incorporated UNH 2.85%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 20, 2024 $5.40216 Dec 20, 2024
Dec 20, 2023 $1.91322 Dec 20, 2023
Dec 20, 2022 $0.61624 Dec 20, 2022
Dec 20, 2021 $14.02528 Dec 20, 2021
Dec 20, 2019 $1.43164 Dec 20, 2019
Dec 20, 2018 $4.77761 Dec 20, 2018
Full Dividend History